Sample Sales Aid for Pharmaceutical Representatives

Dr. Shakeel Zulfiqar

PUSTEXA is a fictional brand name created for this portfolio sample. Spesolimab is a real IL-36 receptor antagonist approved for GPP. Clinical data cited are from published trials (Effisayil 1 and Effisayil 2) and the US Prescribing Information, used for illustrative purposes only. This document is not intended for distribution and does not constitute medical advice.

Stay Updated, Latest News

This website contains affiliate links, and we may earn a commission at no extra cost to you.